PCMT1 and lung adenocarcinoma: Recent evidence documents that PCMT1 is an unfavorable prognostic predictor and functions as an oncogene in various cancers, including bladder cancer [15] and lung adenocarcinoma [16], indicating a role for PCMT1 in cancer progression.